Regulatory Updates: Page 33

FDA requires boxed warnings on opioids, benzodiazepine

By DrBicuspid.com staff writers

The U.S. Food and Drug Administration (FDA) announced that it will require boxed warnings for prescription opioid analgesics, opioid-containing cough products, and benzodiazepines.

August 31, 2016

Snuggie maker to drop claims for interdental cleaner

By DrBicuspid.com staff writers

Consumer brand developer and marketer Allstar Products Group, maker of the Snuggie and other products, will voluntarily remove some claims in its television commercial for Dr. Hart's Power Floss after an inquiry by the Better Business Bureau.

August 28, 2016

JAMA editorial: San Francisco sugary drink decision a victory

By Donna Domino

San Francisco is the first U.S. city to require health warnings on ads for sodas and sugary drinks. The pioneering law is a victory over the beverage industry's efforts to manipulate science, according to the authors of an editorial in the Journal of the American Medical Association (JAMA).

August 8, 2016

DentaQuest to purchase stake in Ore. dental plan

By DrBicuspid.com staff writers

DentaQuest has received regulatory approval to purchase 80% of a company that operates more than 40 dental clinics in Oregon.

August 7, 2016

U.S. bill to fight opioid epidemic becomes law

By DrBicuspid.com staff writers

A U.S. bill that provides resources to battle the ongoing opioid epidemic was signed into law by President Barack Obama on July 22.

July 27, 2016

Advertising body backs Oral-B toothbrush claims

By DrBicuspid.com staff writers

The National Advertising Division of the Council of Better Business Bureaus has determined that Procter & Gamble's advertising claims about the superior clean of its Oral-B Pro 5000 and 70000 electric toothbrushes are supported by scientific evidence.

July 26, 2016